456 related articles for article (PubMed ID: 24030732)
1. The complement cascade and renal disease.
Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
[TBL] [Abstract][Full Text] [Related]
2. Molecules Great and Small: The Complement System.
Mathern DR; Heeger PS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
[TBL] [Abstract][Full Text] [Related]
3. Complement and glomerular diseases.
Popat RJ; Robson MG
Nephron Clin Pract; 2014; 128(3-4):238-42. PubMed ID: 25412932
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated kidney diseases.
Poppelaars F; Thurman JM
Mol Immunol; 2020 Dec; 128():175-187. PubMed ID: 33137606
[TBL] [Abstract][Full Text] [Related]
5. Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.
Noris M; Remuzzi G
Am J Kidney Dis; 2015 Aug; 66(2):359-75. PubMed ID: 26032627
[No Abstract] [Full Text] [Related]
6. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
Front Immunol; 2020; 11():599417. PubMed ID: 33362783
[TBL] [Abstract][Full Text] [Related]
8. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Zhang Y; Meyer NC; Fervenza FC; Lau W; Keenan A; Cara-Fuentes G; Shao D; Akber A; Fremeaux-Bacchi V; Sethi S; Nester CM; Smith RJH
Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
[TBL] [Abstract][Full Text] [Related]
9. Complement and glomerular disease: new insights.
Pickering M; Cook HT
Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
[TBL] [Abstract][Full Text] [Related]
10. Complement and kidney disease.
Cook HT
Curr Opin Nephrol Hypertens; 2013 May; 22(3):295-301. PubMed ID: 23508058
[TBL] [Abstract][Full Text] [Related]
11. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
[TBL] [Abstract][Full Text] [Related]
12. Complement Recognition Pathways in Renal Transplantation.
Nauser CL; Farrar CA; Sacks SH
J Am Soc Nephrol; 2017 Sep; 28(9):2571-2578. PubMed ID: 28663231
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against alternative complement pathway proteins in renal pathologies.
Nozal P; López-Trascasa M
Nefrologia; 2016; 36(5):489-495. PubMed ID: 27267919
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
[TBL] [Abstract][Full Text] [Related]
15. The role of the alternative pathway of complement activation in glomerular diseases.
Łukawska E; Polcyn-Adamczak M; Niemir ZI
Clin Exp Med; 2018 Aug; 18(3):297-318. PubMed ID: 29450785
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in renal disease.
West CD
Uremia Invest; 1984-1985; 8(3-4):225-35. PubMed ID: 6545495
[TBL] [Abstract][Full Text] [Related]
17. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Corvillo F; Okrój M; Nozal P; Melgosa M; Sánchez-Corral P; López-Trascasa M
Front Immunol; 2019; 10():886. PubMed ID: 31068950
[TBL] [Abstract][Full Text] [Related]
18. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
Zipfel PF; Wiech T; Rudnick R; Afonso S; Person F; Skerka C
Front Immunol; 2019; 10():2166. PubMed ID: 31611870
[TBL] [Abstract][Full Text] [Related]
19. Complement and Complement Targeting Therapies in Glomerular Diseases.
Andrighetto S; Leventhal J; Zaza G; Cravedi P
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888179
[TBL] [Abstract][Full Text] [Related]
20. Is primary membranous nephropathy a complement mediated disease?
Reinhard L; Stahl RAK; Hoxha E
Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
